YAN lAVROVSKY

CEO & Director Clinical Development
Yan Lavrovsky has extensive experience in drug discovery with roles covering executive research positions, scientific and tutorial work.

Dr. Lavrovsky is Vice President for Clinical Development at ChemDiv, where he oversees the development of several discovery platforms in CNS and oncology through the clinical phases.
Before joining ChemDiv in 2006 Dr. Lavrovsky held research positions at Serono, Geneva, Switzerland and Boston, Massachusetts. At Serono Dr. Lavrovsky led several development programs in oncology and fibrotic diseases. During these years he earned his “Mini-MBA” in business of biopharmaceutical sciences from Babson School of Executive Education, Babson College, Boston, MA.

From 1995 to 2001 Dr. Lavrovsky was a faculty member at the University of Texas, Health Science Center, in the Department of Cellular and Structural Biology. During his tenure at the University of Texas, Dr. Lavrovsky was a principal investigator on NIH-funded projects.

Dr. Lavrovsky is the author of more than 50 original reviews, original research articles, patents, and various book chapters. He is a trained physician with a Ph.D. in Molecular Biology and completed post-doctoral training at the Rockefeller University, New York, NY.